Toxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data.

  title={Toxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data.},
  author={Pirkko Kriikku and Anna Pelander and Ilpo Rasanen and Ilkka Ojanper{\"a}},
  journal={Forensic science international},

Figures and Tables from this paper

Blood concentrations of new synthetic opioids

Blood levels of new opioids are extremely difficult to interpret as their high potency creates a risk of respiratory depression even at low doses, which makes it impossible to define concentration ranges, especially the minimum fatal concentrations.

U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market

The evidence demonstrates that U-47700 is a potent μ-opioid receptor agonist, which poses a serious risk for overdosing and death, however, most analogs of U- 47700 appear to be less potent and have been detected infrequently in forensic specimens.

New psychoactive substances: a review and updates

These four classes of NPS are reviewed, including their chemical structures, mechanism of action, modes of use, intended intoxicant effects, and their associated physical and mental health harms.


This review surveys advancements in the areas of sample preparation, gas and liquid chromatography-mass spectrometry, as well as the rapidly emerging field of ambient ionization mass spectromaetry.

Designer drugs: mechanism of action and adverse effects

Because of their novelty, designer drugs may remain undetected by routine drug screening, thus hampering evaluations of adverse effects.

Squaring Things Up With R2: What it is, What it Can (and cannot) Tell You.

The coefficient of correlation (r) and the coefficient of determination (R2) have long been used in analytical chemistry, bioanalysis and forensic toxicology as figures demonstrating linearity of the calibration data in method validation but should not be used for this purpose in the context of model fitting for prediction.



Quantification of U-47700 and its metabolites in plasma by LC-MS/MS.

A Fatality Related to the Synthetic Opioid U-47700: Postmortem Concentration Distribution.

An evaluation of the distribution of postmortem concentrations of 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) in a fatality attributed principally to the drug is presented.

Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.

Given the widespread geographical distribution and increase in prevalence in postmortem casework, toxicology testing should be expanded to include testing for "designer opioids" in cases with histories consistent with opioid overdose but with no traditional opioids present or insufficient quantities to account for death.

A case of U-47700 overdose with laboratory confirmation and metabolite identification

U-47700 is a potent μ-opioid receptor agonist and has recently been used recreationally, contributing to hospitalizations and likely deaths in the community and appears to be an appropriate marker of use in a serum sample.

Two cases of intoxication with new synthetic opioid, U-47700

Two patients presenting after insufflation of U-47700, a relatively new agent that is easy to obtain over the internet and has the potential to cause significant morbidity and mortality are reported.

Postmortem concentration distribution in fatal cases involving the synthetic opioid U-47700

The data concerning U-47700 concentration distribution in postmortem specimens collected after two lethal intoxications showed femoral blood concentrations were lower than the urine/heart blood concentrations and can be defined as high when compared with toxic morphine levels, well known that the interpretation of postmortem drug concentration is a big challenge.

Quantification of U-47700 and its metabolites: N-desmethyl-U-47700 and N,N-didesmethyl-U-47700 in 12 autopsy blood samples employing SPE/LC–ESI-MS-MS

PurposeThe paper presents a report on the comprehensive assessment of a novel synthetic opioid (NSO) termed U-47700, and its two metabolites: N-desmethyl-U-47700 and N,N-didesmethyl-U-47700 in

Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class

A patient who suffered respiratory failure and depressed level of consciousness after recreationally using a novel synthetic opioid labeled U-47700 was treated with naloxone, which completely reversed his opioid poisoning.

A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.

The coronial case reported here illustrates the application of retrospective processing of HRMS data in the detection of emerging NPS, revealing the presence of designer benzodiazepines, diclazepam and flubromazep am as well as the psychedelic drug 2,5-dimethoxy-4-chloroamphetamine.